1. 1998-Protocol 0802D1-324-US, Metabolic Study, “A Randomized Double-Blind, Placebo and Active-Controlled, Parallel, Multicenter Study to Access the Safety and Efficacy of 1 1/2 –Day Combinations of 17-Estradiol/Norethindrone Acetate Transdermal Delivery System for Relief of Menopausal Vasomotor Symptoms and Reduction of Endometrial Hyperplasia”, Wyeth-Ayerst Research.
2. NIH Office of Human Subject Research computer based training course on the protection of Human Research Subjects, Nov. 21, 2000. |
